Self-precipitating pharmaceutical formulations for the modified release of active principle

Details for Australian Patent Application No. 2008248603 (hide)

Owner Flamel Technologies

Inventors Checot, Frederic; Meyrueix, Remi; Bonnet Gonnet, Cecile; Chan, You-Ping; Breyne, Olivier

Agent Spruson & Ferguson

Pub. Number AU-A-2008248603

PCT Pub. Number WO2008/135562

Priority 0703186 03.05.07 FR

Filing date 5 May 2008

Wipo publication date 13 November 2008

International Classifications

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

5 November 2009 PCT application entered the National Phase

  PCT publication WO2008/135562 Priority application(s): WO2008/135562

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008248604-Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof

2008248602-Modified-release particles based on polyelectrolytes and on an active principle and pharmaceutical formulations containing these particles